- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04265625
Routine Use of FIBERoptic Bronchoscopic Guidance in Percutaneous TRACHeostomy (FIBERTRACH)
The Role of Routine Fiberoptic Bronchoscopic Guidance During Percutaneous Tracheostomy. A Prospective Randomized Trial
Tracheostomy is one of the most frequently performed techniques in intensive care units. For some authors endoscopic guide as part of the percutaneous tracheostomy (PT) might reduces the incidence of serious complications. However, for others, endoscopic guide increases the procedure cost, increases airway pressure and PaCO2 and sometimes requires the presence of another physician. International guidelines conclude that there is insufficient evidence to support the routine use of bronchoscopy during PT in order to decrease the number of complications. In addition the routine use of endoscopic guide is heterogeneous according the results of six published nation surveys. Extensive randomized trials to compare PT with endoscopic guide and without endoscopic guide are needed in order to clarify this controversial issue. This constitutes the justification of this trial.
Hypothesis: Percutaneous tracheotomy performed under endoscopic guide decreases the incidence of perioperative complications of the procedure.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background
Tracheostomy is one of the most frequently performed techniques in intensive care units (ICU). A few years after the description of the percutaneous dilatational tracheostomy (PDT), endoscopic guide as part of the technique was performed in four patients. The authors concluded that the endoscopic guide provided advantages to the realization of PDT. Other authors have state that endoscopy, significantly reduces the incidence of serious complications such as posterior tracheal tears, false passage, pneumothorax and subcutaneous emphysema. However, currently endoscopic guide as part of the percutaneous tracheostomy is controversial. Although for some authors its use reduces the number of complications, others found that endoscopic guide increases the procedure cost, increases airway pressure and PaCO2 and sometimes requires the presence of another physician. Thus, some do not consider it necessary when the physicians have enough experience with percutaneous tracheostomy. International guidelines conclude that there is insufficient evidence to support the routine use of bronchoscopy during percutaneous tracheostomy in order to decrease the number of complications. In addition the routine use of endoscopic guide is heterogeneous according the published surveys. Specifically, in Spain its use was the lowest of the six published nation surveys. Extensive randomized trials to compare percutaneous tracheostomy with endoscopic guide and without endoscopic guide are needed in order to clarify this controversial issue. This constitutes the justification of this trial.
Hypothesis
Percutaneous tracheotomy performed under endoscopic guidance decreases the incidence of perioperative complications of the procedure.
Main goal
- - To assess the incidence of perioperative complications of percutaneous tracheotomy under endoscopic guide versus blind percutaneous tracheotomy.
- - To assess the ventilatory parameters during percutaneous tracheostomy with and without endoscopic control.
Methodology
Prospective, multicenter randomized study. Patients admitted to the ICU who need tracheostomy due to prolonged mechanical ventilation, who do not have neither contraindications to perform the percutaneous technique nor contraindications to perform fibrobronchoscopy will be randomized.
The percutaneous tracheostomy will be carried out with the single-step dilation method. For its realization, the usual protocol will be followed.
The included patients will be randomized 1:1 (percutaneous tracheostomy with endoscopic guide vs percutaneous tracheostomy without endoscopic guide). The randomization system will be by closed envelope. A sample size of 221 patients in each branch has been calculated.
The percutaneous tracheostomy and fiberoptic bronchoscopy will be performed by staff with experience with both procedures.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jose Manuel Añon, MD, PhD
- Phone Number: +(34) 912071307
- Email: jmaelizalde@gmail.com
Study Locations
-
-
-
Madrid, Spain, 28046
- Recruiting
- Hospital Universitario La Paz
-
Contact:
- Jose M. Añon, MD,PhD
- Phone Number: +(34) 912071307
- Email: jmaelizalde@gmail.com
-
Madrid, Spain
- Recruiting
- Hospital Universitario Infanta Leonor
-
Contact:
- Covadonga Rodriguez, MD
- Email: covarodriguezruiz@gmail.com
-
Madrid, Spain
- Recruiting
- Hospital Universitario Rey Juan carlos
-
Contact:
- Manuel Perez-Marquez, MD
- Email: mapemar@msn.com
-
Sub-Investigator:
- Manuel Perez-Marquez, MD
-
Toledo, Spain
- Recruiting
- Hospital Universitario de Toledo
-
Contact:
- Margarita Marquez, MD
- Email: margui1992@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients over 18 years old requiring tracheotomy due to prolonged mechanical ventilation
- That Family members or legal representatives have signed the information sheet and informed consent
Exclusion Criteria:
- Patients with increased intracranial pressure according to intracranial pressure monitoring or suspected.
- Patients who have any absolute or relative contraindication for the percutaneous tracheostomy realization
- Patients with difficult airway
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: blind tracheotomy
no endoscopic guidance tracheotomy
|
|
Experimental: endoscopic guidance tracheotomy
With endoscopic guidance tracheotomy
|
Percutaneous tracheotomy performed by endoscopic guidance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of patients with bleeding
Time Frame: 24 hours
|
Bleeding with haemodynamic derangement or needing surgical review or transfusion of packed red cells.
|
24 hours
|
Number of patients with hypoxemia
Time Frame: During the procedure
|
Hypoxemia: Oxygen arterial saturation (SaO2) < 85% during more than 90 seconds and/or arrhythmia or cardiac arrest related to hypoxemia.
|
During the procedure
|
Number of patients in whom a loss of airway has ocurred
Time Frame: During the procedure
|
Loss of airway: Failure to be able to access the airway > 30 seconds.
|
During the procedure
|
Number of patients with atelectasis
Time Frame: 24 hours
|
Atelectasis: Total or partial lung collapse not present before the technique, evidenced at postoperative control.
|
24 hours
|
Number of patients with hypotension
Time Frame: During the procedure
|
Hypotension requiring treatment with vasopressors or >1000 ml of fluids during the procedure.
|
During the procedure
|
Number of patients with barotrauma
Time Frame: 24 hours
|
Barotrauma: Subcutaneous emphysema, mediastinal emphysema or pneumothorax related to the technique.
|
24 hours
|
Number of patients with posterior tracheal wall injury
Time Frame: During the procedure
|
Posterior tracheal wall injury: Injury to membranous trachea from needle, guide or dilator.
|
During the procedure
|
Number of patients in whom false passage has ocurred
Time Frame: During the procedure
|
False passage: Dilatation or insertion of the cannula out of the trachea lumen.
|
During the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peak airway pressure
Time Frame: During the procedure
|
Maximum peak airway pressure (cmH2O)
|
During the procedure
|
Plateau pressure
Time Frame: During the procedure
|
Maximum plateau pressure (cmH2O)
|
During the procedure
|
Tidal volume
Time Frame: During the procedure
|
Minimum tidal volume (mL)
|
During the procedure
|
Arterial Blood Gas
Time Frame: 2 hours
|
Arterial blood gase at the beginning and the end of the procedure
|
2 hours
|
Oxygen saturation (SaO2)
Time Frame: During the procedure
|
Minimum arterial oxygen saturation (SaO2)
|
During the procedure
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mortality
Time Frame: 90 days
|
All-cause mortality at hospital discharge
|
90 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jose Manuel Añon, MD. PhD, Hospital Universitario La Paz. IdiPAZ
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HULP5455
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tracheostomy Complication
-
Rush University Medical CenterWithdrawnTracheostomy ComplicationUnited States
-
Ohio State UniversityWithdrawnTracheostomy ComplicationUnited States
-
Diskapi Yildirim Beyazit Education and Research...CompletedTracheostomy Complication | Percutaneous Tracheostomy | High-frequency Jet VentilationTurkey
-
Rigshospitalet, DenmarkRecruitingTracheostomy ComplicationDenmark
-
HULYA TOPCUSerhat OzciftciCompletedTracheostomy ComplicationTurkey
-
The First Affiliated Hospital of Shanxi Medical...Completed
-
Assiut UniversityCompletedTracheostomy ComplicationEgypt
-
Melike CengizCompletedTracheostomy ComplicationTurkey
-
Changi General HospitalUnknownTracheostomy ComplicationSingapore
-
Hadassah Medical OrganizationUnknownOther Tracheostomy Complication
Clinical Trials on endoscopic guidance
-
Changhai HospitalUnknownColorectal Adenoma | Colorectal PolypChina
-
University of California, San FranciscoEnvironmental Protection Agency (EPA)CompletedSinusitis | Nasal PolypsUnited States
-
Emergency Medical Service of the Central Bohemian...Masaryk Hospital Usti nad LabemCompleted
-
Shanghai MicroPort Medical (Group) Co., Ltd.RecruitingOptical Coherence Tomography | Angiography | Intravascular UltrasoundChina
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingCoronary Artery DiseaseChina
-
Beth Israel Deaconess Medical CenterActive, not recruiting
-
Complejo Hospitalario Universitario de GranadaUnknownFacet Joint Pain | Facet Syndrome of Lumbar Spine | Facet Joints; DegenerationSpain
-
Children's Hospital Medical Center, CincinnatiWithdrawnCatheterization, PeripheralUnited States
-
The Cleveland ClinicCompletedTotal Knee Replacement SurgeryUnited States
-
West China HospitalUnknownPortal Hypertension